Clinical Trial Update: Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating two dosing strategies of epoetin alfa in adults with chronic kidney disease on hemodialysis. The study has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Epogen (epoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Renal Insufficiency, Chronic, Anemia | Phase 4 | Status: COMPLETED | Results posted: 2017-05-12